loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 125526 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 GLAXOSMITHKLINE LLC (1)

filter

01 INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER (1)

filter

01 Blank (1)

filter

01 NUCALA (1)

filter

01 Blank (1)

Contact Supplier
  • FDA
  • EDQM
  • WHO-GMP
URL Supplier Web Content
INJECTABLE; SUBCUT...
100MG
125526
NUCALA
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 125526

Looking for FDA Orange Book APPLICATION 125526 1

19

GSK, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is MEPOLIZUMAB, with a corresponding application number 125526.

With a dosage strength 100MG

Dosage Form Route INJECTABLE; SUBCUTANEOUS LYOPHILIZED POWER

Post Enquiry
POST ENQUIRY